Aethlon Medical, Inc. (AEMD) Stock

Aethlon Medical, Inc. is a pioneering medical technology company based in the United States, dedicated to developing innovative products aimed at diagnosing and treating life-threatening diseases affecting organs. Central to its portfolio is the Aethlon Hemopurifier, an advanced immunotherapeutic device currently in clinical stages. This device is designed to effectively remove tumor-derived exosomes and life-threatening viruses from the circulatory system, demonstrating promising capabilities in combatting infections such as COVID-19 and its variants, along with associated exosomes.

In collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center, Aethlon Medical is actively conducting studies focused on addressing head and neck cancer, underscoring its commitment to advancing cancer research and treatment outcomes. Founded in 1999 and headquartered in San Diego, California, the company continues to push the boundaries of medical innovation, leveraging strategic partnerships and cutting-edge technology to develop solutions that meet critical medical needs.

Aethlon Medical's mission is rooted in improving patient care through transformative medical technologies. With a strong emphasis on combating life-threatening diseases and enhancing organ function, the company remains at the forefront of medical advancements, striving to bring effective and innovative treatments to patients worldwide.